|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.37 USD | +1.61% |
|
+6.06% | -18.02% |
| 07-21 | RBC Cuts Price Target on FMC to $12 From $14, Keeps Sector Perform Rating | MT |
| 07-08 | FMC Files First Global Regulatory Submission for Rimisoxafen to US EPA | MT |
Main competitors
| 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|
| 14 | ||||||||
| 20 | ||||||||
| - | - | - | - | |||||
| 5 | ||||||||
| - | - | 4 | ||||||
| 18 | ||||||||
| 26 | ||||||||
| 6 | ||||||||
| 13 | ||||||||
| 9 | ||||||||
| - | 1 | |||||||
| 3 | ||||||||
| - | - | |||||||
| - | 1 | |||||||
| 2 | ||||||||
| 6 | ||||||||
| Average | 9 | |||||||
| Weighted average by Cap. | 15 |
- Stock Market
- Stocks
- FMC Stock
- Sector FMC Corporation
- Sector revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















